Arcus and Gilead terminate development for etrumadenant in prostate cancer
However, the adenosine receptor antagonist is still being developed for the treatment of metastatic colorectal cancer.
However, the adenosine receptor antagonist is still being developed for the treatment of metastatic colorectal cancer.
What's Your Reaction?
